Dendritic cells (DCs) are located in the mucosae and the lymphoid tissues. They are proposed to be among the first cells to encounter HIV during sexual transmission.
The main populations of DCs include myeloid DCs and plasmacytoid DCs in the blood, and Langerhans cells in the tissues. Myeloid DCs, plasmacytoid DCs and Langerhans cells are all susceptible to infection with HIV; they can also transfer HIV to CD4+ T cells.
Follicular DCs can trap and maintain large quantities of HIV, thereby functioning as a persistent reservoir of virus.
Immunomodulation of DCs by HIV infection is a key aspect of viral pathogenesis, particularly through the modulation or interference of the antigen-presenting function of DCs.
DCs express high levels of C-type lectins, including DC-specific intercellular adhesion molecule 3 (ICAM3)-grabbing non-integrin (DC-SIGN; also known as CD209). C-type lectins are the main HIV attachment factors at the surface of dermal and mucosal DCs.
DCs have DC-SIGN-dependent and DC-SIGN-independent mechanisms of HIV trans-infection of CD4+ T cells. The efficiency of HIV transmission can be increased by maturation of DCs.
The transfer of virus from DCs to CD4+ T cells occurs in three discrete steps. First, DCs capture and bind HIV. Second, HIV traffics within these DCs. And third, HIV is transferred to CD4+ T cells by a process that is known as trans-infection.
DC-mediated HIV trans-infection might occur by several distinct processes that can take place concurrently, including rapid HIV trans-infection through infectious synapses and exosome-associated viruses. HIV transmission can also be mediated by de novo viral production in DCs, known as cis-infection.
Elucidating the interactions of HIV with DCs will be vital to uncover the contribution of DCs to viral pathogenesis.
Dendritic cells (DCs) are crucial for the generation and the regulation of adaptive immunity. Because DCs have a pivotal role in marshalling immune responses, HIV has evolved ways to exploit DCs, thereby facilitating viral dissemination and allowing evasion of antiviral immunity. Defining the mechanisms that underlie cell–cell transmission of HIV and understanding the role of DCs in this process should help us in the fight against HIV infection. This Review highlights the latest advances in our understanding of the interactions between DCs and HIV, focusing on the mechanisms of DC-mediated viral dissemination.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
United Nations Programme on HIV/AIDS. 2006 Report on the Global AIDS epidemic 8 (UNAIDS, Geneva, 2006).
Shattock, R. J. & Moore, J. P. Inhibiting sexual transmission of HIV-1 infection. Nature. Rev. Microbiol. 1, 25–34 (2003).
Pope, M. & Haase, A. T. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nature Med. 9, 847–852 (2003).
Steinman, R. M. et al. The interaction of immunodeficiency viruses with dendritic cells. Curr. Top. Microbiol. Immunol. 276, 1–30 (2003).
Haase, A. T. Perils at mucosal front lines for HIV and SIV and their hosts. Nature Rev. Immunol. 5, 783–792 (2005).
Cameron, P. U. et al. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 257, 383–387 (1992).
Pope, M. et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78, 389–398 (1994).
McDonald, D. et al. Recruitment of HIV and its receptors to dendritic cell–T cell junctions. Science 300, 1295–1297 (2003). First paper to describe infectious synapses between DCs and T cells.
Arrighi, J. F. et al. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 200, 1279–1288 (2004).
Wiley, R. D. & Gummuluru, S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc. Natl Acad. Sci. USA 103, 738–743 (2006). Recent paper that describes HIV trans -infection mediated by exosome release from immature MDDCs.
Kawamura, T. et al. R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc. Natl Acad. Sci. USA 100, 8401–8406 (2003).
Turville, S. G. et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103, 2170–2179 (2004). Reports the rapid transmission and long-term transmission of HIV by human MDDCs.
Nobile, C. et al. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J. Virol. 79, 5386–5399 (2005).
Lore, K., Smed-Sorensen, A., Vasudevan, J., Mascola, J. R. & Koup, R. A. Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells. J. Exp. Med. 201, 2023–2033 (2005).
Burleigh, L. et al. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells. J. Virol. 80, 2949–2957 (2006).
Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811 (2000).
Liu, Y. J. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106, 259–262 (2001).
Rissoan, M. C. et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283, 1183–1186 (1999).
Cella, M. et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nature Med. 5, 919–923 (1999).
Siegal, F. P. et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835–1837 (1999).
Zaitseva, M. et al. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nature Med. 3, 1369–1375 (1997).
Valladeau, J. et al. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur. J. Immunol. 29, 2695–2704 (1999).
Niedecken, H., Lutz, G., Bauer, R. & Kreysel, H. W. Langerhans cell as primary target and vehicle for transmission of HIV. Lancet 2, 519–520 (1987).
Berger, R. et al. Isolation of human immunodeficiency virus type 1 from human epidermis: virus replication and transmission studies. J. Invest. Dermatol. 99, 271–277 (1992).
Soto-Ramirez, L. E. et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 271, 1291–1293 (1996).
Ludewig, B., Gelderblom, H. R., Becker, Y., Schafer, A. & Pauli, G. Transmission of HIV-1 from productively infected mature Langerhans cells to primary CD4+ T lymphocytes results in altered T cell responses with enhanced production of IFN-γ and IL-10. Virology 215, 51–60 (1996).
Blauvelt, A. et al. Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. J. Clin. Invest. 100, 2043–2053 (1997).
Granelli-Piperno, A., Delgado, E., Finkel, V., Paxton, W. & Steinman, R. M. Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 72, 2733–2737 (1998).
Granelli-Piperno, A., Finkel, V., Delgado, E. & Steinman, R. M. Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells. Curr. Biol. 9, 21–29 (1999).
Kawamura, T. et al. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J. Exp. Med. 192, 1491–1500 (2000).
Patterson, S., Rae, A., Hockey, N., Gilmour, J. & Gotch, F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J. Virol. 75, 6710–6713 (2001).
Donaghy, H. et al. Loss of blood CD11c+ myeloid and CD11c− plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 98, 2574–2576 (2001).
Smed-Sorensen, A. et al. Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J. Virol. 79, 8861–8869 (2005).
Granelli-Piperno, A. et al. Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J. Exp. Med. 184, 2433–2438 (1996).
Rubbert, A. et al. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J. Immunol. 160, 3933–3941 (1998).
Turville, S. G. et al. HIV gp120 receptors on human dendritic cells. Blood 98, 2482–2488 (2001).
Ignatius, R. et al. The immunodeficiency virus coreceptor, Bonzo/STRL33/TYMSTR, is expressed by macaque and human skin- and blood-derived dendritic cells. AIDS Res. Hum. Retroviruses 16, 1055–1059 (2000).
Beaulieu, S. et al. Expression of a functional eotaxin (CC chemokine ligand 11) receptor CCR3 by human dendritic cells. J. Immunol. 169, 2925–2936 (2002).
Cameron, P. U., Forsum, U., Teppler, H., Granelli-Piperno, A. & Steinman, R. M. During HIV-1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion. Clin. Exp. Immunol. 88, 226–236 (1992).
Pope, M., Gezelter, S., Gallo, N., Hoffman, L. & Steinman, R. M. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells. J. Exp. Med. 182, 2045–2056 (1995).
McIlroy, D. et al. Infection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients. J. Virol. 69, 4737–4745 (1995).
Moris, A. et al. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 103, 2648–2654 (2004).
Chiu, Y. L. et al. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435, 108–114 (2005).
Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998).
Tenner-Racz, K. et al. Immunohistochemical, electron microscopic and in situ hybridization evidence for the involvement of lymphatics in the spread of HIV-1. AIDS 2, 299–309 (1988).
Heath, S. L., Tew, J. G., Szakal, A. K. & Burton, G. F. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377, 740–744 (1995).
Burton, G. F., Keele, B. F., Estes, J. D., Thacker, T. C. & Gartner, S. Follicular dendritic cell contributions to HIV pathogenesis. Semin. Immunol. 14, 275–284 (2002).
Schacker, T. et al. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J. Infect. Dis. 181, 354–357 (2000).
Spiegel, H., Herbst, H., Niedobitek, G., Foss, H. D. & Stein, H. Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells. Am. J. Pathol. 140, 15–22 (1992).
Smith, B. A. et al. Persistence of infectious HIV on follicular dendritic cells. J. Immunol. 166, 690–696 (2001).
Popov, S., Chenine, A. L., Gruber, A., Li, P. L. & Ruprecht, R. M. Long-term productive human immunodeficiency virus infection of CD1a-sorted myeloid dendritic cells. J. Virol. 79, 602–608 (2005).
Romani, N. et al. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180, 83–93 (1994).
Geijtenbeek, T. B. et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575–585 (2000). First paper to identify DC-SIGN.
de Jong, E. C. et al. Microbial compounds selectively induce TH1 cell-promoting or TH2 cell-promoting dendritic cells in vitro with diverse TH cell-polarizing signals. J. Immunol. 168, 1704–1709 (2002).
Sanders, R. W. et al. Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J. Virol. 76, 7812–7821 (2002).
Turville, S. G. et al. Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunol. 3, 975–983 (2002). Characterizes a variety of HIV-binding receptors expressed by DC subsets.
Jefford, M. et al. Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood 102, 1753–1763 (2003).
Granelli-Piperno, A. et al. Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction. J. Immunol. 175, 4265–4273 (2005). Reports that DC-SIGN is not required for DCs to transmit HIV and stimulate T cells.
Macatonia, S. E., Lau, R., Patterson, S., Pinching, A. J. & Knight, S. C. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 71, 38–45 (1990).
Knight, S. C., Patterson, S. & Macatonia, S. E. Stimulatory and suppressive effects of infection of dendritic cells with HIV-1. Immunol. Lett. 30, 213–218 (1991).
Lore, K. et al. Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS 16, 683–692 (2002).
Granelli-Piperno, A., Golebiowska, A., Trumpfheller, C., Siegal, F. P. & Steinman, R. M. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl Acad. Sci. USA 101, 7669–7674 (2004).
Granelli-Piperno, A., Shimeliovich, I., Pack, M., Trumpfheller, C. & Steinman, R. M. HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood. J. Immunol. 176, 991–998 (2006).
Fidler, S. J. et al. An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones. Immunology 89, 46–53 (1996).
Sapp, M. et al. Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses. Immunol. Lett. 66, 121–128 (1999).
Messmer, D. et al. Endogenously expressed nef uncouples cytokine and chemokine production from membrane phenotypic maturation in dendritic cells. J. Immunol. 169, 4172–4182 (2002).
Izmailova, E. et al. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nature Med. 9, 191–197 (2003).
Fanales-Belasio, E. et al. Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses. J. Immunol. 168, 197–206 (2002).
Quaranta, M. G., Tritarelli, E., Giordani, L. & Viora, M. HIV-1 Nef induces dendritic cell differentiation: a possible mechanism of uninfected CD4+ T cell activation. Exp. Cell Res. 275, 243–254 (2002).
Andrieu, M. et al. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes. AIDS Res. Hum. Retroviruses 17, 1365–1370 (2001).
Shinya, E. et al. Endogenously expressed HIV-1 nef down-regulates antigen-presenting molecules, not only class I MHC but also CD1a, in immature dendritic cells. Virology 326, 79–89 (2004).
Spira, A. I. et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183, 215–225 (1996).
Hu, J., Miller, C. J., O'Doherty, U., Marx, P. A. & Pope, M. The dendritic cell–T cell milieu of the lymphoid tissue of the tonsil provides a locale in which SIV can reside and propagate at chronic stages of infection. AIDS Res. Hum. Retroviruses 15, 1305–1314 (1999).
Hu, J., Gardner, M. B. & Miller, C. J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74, 6087–6095 (2000).
Hu, Q. et al. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J. Exp. Med. 199, 1065–1075 (2004).
Lederman, M. M., Offord, R. E. & Hartley, O. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nature Rev. Immunol. 6, 371–382 (2006).
Geijtenbeek, T. B. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587–597 (2000). Characterizes the role of DC-SIGN in increasing HIV trans -infection.
Lin, G. et al. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 77, 1337–1346 (2003).
Pohlmann, S. et al. DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions. J. Virol. 75, 10523–10526 (2001).
Wu, L., Martin, T. D., Han, Y. C., Breun, S. K. & KewalRamani, V. N. Trans-dominant cellular inhibition of DC-SIGN-mediated HIV-1 transmission. Retrovirology 1, 14 (2004).
Lee, B. et al. Cis expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J. Virol. 75, 12028–12038 (2001).
Trumpfheller, C., Park, C. G., Finke, J., Steinman, R. M. & Granelli-Piperno, A. Cell type-dependent retention and transmission of HIV-1 by DC-SIGN. Int. Immunol. 15, 289–298 (2003).
Nobile, C., Moris, A., Porrot, F., Sol-Foulon, N. & Schwartz, O. Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN. J. Virol. 77, 5313–5323 (2003).
Engering, A., Van Vliet, S. J., Geijtenbeek, T. B. & Van Kooyk, Y. Subset of DC-SIGN+ dendritic cells in human blood transmits HIV-1 to T lymphocytes. Blood 100, 1780–1786 (2002).
Gurney, K. B. et al. Binding and transfer of human immunodeficiency virus by DC-SIGN+ cells in human rectal mucosa. J. Virol. 79, 5762–5773 (2005). Shows efficient HIV transmission by DC-SIGN+ immature DCs in human rectal mucosa.
Wu, L. et al. Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN. Proc. Natl Acad. Sci. USA 99, 1568–1573 (2002). Shows DC-SIGN-independent transmission of primate lentiviruses by rhesus macaque DCs.
Wu, L., Martin, T. D., Vazeux, R., Unutmaz, D. & KewalRamani, V. N. Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. J. Virol. 76, 5905–5914 (2002).
Baribaud, F., Pohlmann, S., Leslie, G., Mortari, F. & Doms, R. W. Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells. J. Virol. 76, 9135–9142 (2002).
Gummuluru, S., Rogel, M., Stamatatos, L. & Emerman, M. Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J. Virol. 77, 12865–12874 (2003).
Soilleux, E. J. et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 71, 445–457 (2002).
Krutzik, S. R. et al. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nature Med. 11, 653–660 (2005).
Chehimi, J. et al. HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages. J. Leukoc. Biol. 74, 757–763 (2003).
Nguyen, D. G. & Hildreth, J. E. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol. 33, 483–493 (2003).
Kwon, D. S., Gregorio, G., Bitton, N., Hendrickson, W. A. & Littman, D. R. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 16, 135–144 (2002). Reports that HIV internalization is important for efficient DC-SIGN-mediated transmission of HIV.
Wu, L., Martin, T. D., Carrington, M. & KewalRamani, V. N. Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology 318, 17–23 (2004). Shows that DC-SIGN-mediated transmission of HIV is cell-type dependent and indicates that B cells and DCs that facilitate viral transmission have common features.
Soilleux, E. J. et al. Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J. Pathol. 195, 586–592 (2001).
Jameson, B. et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 76, 1866–1875 (2002).
Engering, A. et al. Dynamic populations of dendritic cell-specific ICAM-3 grabbing nonintegrin-positive immature dendritic cells and liver/lymph node-specific ICAM-3 grabbing nonintegrin-positive endothelial cells in the outer zones of the paracortex of human lymph nodes. Am. J. Pathol. 164, 1587–1595 (2004).
Soilleux, E. J. & Coleman, N. Langerhans cells and the cells of Langerhans cell histiocytosis do not express DC-SIGN. Blood 98, 1987–1988 (2001).
Weissman, D., Li, Y., Orenstein, J. M. & Fauci, A. S. Both a precursor and a mature population of dendritic cells can bind HIV. However, only the mature population that expresses CD80 can pass infection to unstimulated CD4+ T cells. J. Immunol. 155, 4111–4117 (1995).
Frank, I. et al. Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs. J. Virol. 76, 2936–2951 (2002).
Canque, B. et al. The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived in vitro from CD34+ hematopoietic progenitor cells is primarily determined by their maturation stage. Blood 93, 3866–3875 (1999).
Cavrois, M. et al. Human immunodeficiency virus fusion to dendritic cells declines as cells mature. J. Virol. 80, 1992–1999 (2006).
Bakri, Y. et al. The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J. Immunol. 166, 3780–3788 (2001).
Tsunetsugu-Yokota, Y. et al. Efficient virus transmission from dendritic cells to CD4+ T cells in response to antigen depends on close contact through adhesion molecules. Virology 239, 259–268 (1997).
Garcia, E. et al. HIV-1 trafficking to the dendritic cell–T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 6, 488–501 (2005).
Bromley, S. K. et al. The immunological synapse. Annu. Rev. Immunol. 19, 375–396 (2001).
Arrighi, J. F. et al. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J. Virol. 78, 10848–10855 (2004).
Thery, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nature Rev. Immunol. 2, 569–579 (2002).
Pelchen-Matthews, A., Kramer, B. & Marsh, M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162, 443–455 (2003).
Nguyen, D. G., Booth, A., Gould, S. J. & Hildreth, J. E. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 278, 52347–52354 (2003).
Sharova, N., Swingler, C., Sharkey, M. & Stevenson, M. Macrophages archive HIV-1 virions for dissemination in trans. EMBO J. 24, 2481–2489 (2005).
Petit, C. et al. Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes. Virology 286, 225–236 (2001).
Moris, A. et al. Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T cell activation, viral transfer. Blood 108, 1643–1651 (2006).
Brenchley, J. M. et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749–759 (2004).
Mehandru, S. et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761–770 (2004).
Raposo, G. et al. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3, 718–729 (2002).
Lu, W., Arraes, L. C., Ferreira, W. T. & Andrieu, J. M. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nature Med. 10, 1359–1365 (2004). First paper to report a potential therapeutic, DC-based vaccine against chronic HIV infection.
Kundu, S. K. et al. A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients. AIDS Res. Hum. Retroviruses 14, 551–560 (1998).
Curtis, B. M., Scharnowske, S. & Watson, A. J. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl Acad. Sci. USA 89, 8356–8360 (1992).
Rappocciolo, G. et al. DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes. PLoS Pathog. 2, e70 (2006). Recent report that the induction of DC-SIGN expression on activated primary B cells potentiates HIV transmission to T cells.
Tailleux, L. et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197, 121–127 (2003).
Mitchell, D. A., Fadden, A. J. & Drickamer, K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J. Biol. Chem. 276, 28939–28945 (2001).
Feinberg, H., Mitchell, D. A., Drickamer, K. & Weis, W. I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294, 2163–2166 (2001).
Feinberg, H., Guo, Y., Mitchell, D. A., Drickamer, K. & Weis, W. I. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J. Biol. Chem. 280, 1327–1335 (2005).
Sol-Foulon, N. et al. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity 16, 145–155 (2002).
Pohlmann, S., Baribaud, F. & Doms, R. W. DC-SIGN and DC-SIGNR: helping hands for HIV. Trends Immunol. 22, 643–646 (2001).
Ganesh, L. et al. Infection of specific dendritic cells by CCR5-tropic human immunodeficiency virus type 1 promotes cell-mediated transmission of virus resistant to broadly neutralizing antibodies. J. Virol. 78, 11980–11987 (2004).
We thank J. Barbieri for critical reading of the manuscript. L.W. is supported by grants from the National Institutes of Health (United States) and the Research Affairs Committee of the Medical College of Wisconsin (United States). V.N.K. is supported by intramural research funds from the National Institutes of Health. The authors apologize to all those whose work has not been cited as a result of space limitations.
The authors declare no competing financial interests.
- Infectious synapse
Also known as the virological synapse. The cell–cell contact zone between dendritic cells and CD4+ T cells that facilitates transmission of HIV by locally concentrating virus and viral receptors.
Monocyte-derived dendritic cells and certain types of cell that have been transfected with vectors that encode DC-SIGN (DC-specific intercellular adhesion molecule 3 (ICAM3)-grabbing non-integrin) can capture and transfer HIV to target cells without themselves becoming infected.
Small lipid-bilayer vesicles that are released from dendritic cells and other cells. They are composed of plasma membranes or are derived from the membranes of intracellular vesicles. They might contain antigen–MHC complexes and interact with antigen-specific lymphocytes directly, or they might be taken up by antigen-presenting cells.
- C-type lectins
A family of transmembrane proteins (with calcium-dependent activities) that function as cell-adhesion molecules. C-type lectins are involved in the regulation of signalling pathways and recognize specific carbohydrate structures of pathogens and self antigens.
- R5 HIV
An HIV strain that uses CC-chemokine receptor 5 (CCR5) as the co-receptor to gain entry to target cells.
- X4 HIV
An HIV strain that uses CXC-chemokine receptor 4 (CXCR4) as the co-receptor to gain entry to target cells.
- Simian immunodeficiency virus
(SIV). Collectively, different HIV-related lentiviruses isolated from non-human primates. SIV infection of rhesus macaques is an experimental model for HIV infection of humans.
HIV infection of permissive cells through viral-receptor-mediated entry, resulting in the production of progeny viruses. HIV transmission to target cells can be mediated after infection of dendritic cells.
An actin-dependent process by which cells engulf large volumes of fluid.
- Immunological synapse
A junctional structure that is formed between an antigen-presenting cell and a T cell. Important molecules involved in T-cell activation — including the T-cell receptor, signal-transduction molecules and molecular adaptors — accumulate in an orderly manner at this site. Mobilization of the actin cytoskeleton is required for formation of the immunological synapse.
- Multivesicular body
An endocytic organelle that contains small vesicles generated from budding of an endosomal membrane into the lumen of the compartment.
A family of transmembrane proteins that have transmembrane and extracellular domains of different sizes. The function of tetraspanins has not been properly established, but they seem to interact with many other transmembrane proteins and seem to form large multimeric protein networks, which might be involved in intracellular signalling.
- Single-cycle reporter HIV
An infectious HIV vector that can establish an integrated provirus but cannot undergo additional cycles of replication, owing to an inactivated viral envelope gene. The viral genome encodes a reporter gene (such as firefly luciferase or green fluorescent protein), and this gene is expressed on integration of viral DNA in permissive target cells, enabling measurement of infectivity.
About this article
Cite this article
Wu, L., KewalRamani, V. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol 6, 859–868 (2006). https://doi.org/10.1038/nri1960
This article is cited by
Blood monocyte and dendritic cell profiles among people living with HIV with Mycobacterium tuberculosis co-infection
BMC Immunology (2023)
Immune parameters of HIV susceptibility in the female genital tract before and after penile-vaginal sex
Communications Medicine (2022)
The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility
Scientific Reports (2020)
Tetraspanin 7 and its closest paralog tetraspanin 6: membrane organizers with key functions in brain development, viral infection, innate immunity, diabetes and cancer
Medical Microbiology and Immunology (2020)
Nature Microbiology (2019)